We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
-34.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.5M
AUM Growth
-$2.81M
Cap. Flow
+$6.2M
Cap. Flow %
33.6%
Top 10 Hldgs %
79.94%
Holding
88
New
11
Increased
–
Reduced
13
Closed
13

Top Buys

Rank Stock Value
1
MMAT
Meta Materials Inc. Common Stock
MMAT
+$6.52M
2
SLS icon
SELLAS Life Sciences
SLS
+$2.72M
3
ETNB
89bio
ETNB
+$1.21M
4
APLT
Applied Therapeutics
APLT
+$1.11M
5
SKYAW
SkyAI Inc
SKYAW
+$343K

Top Sells

Rank Stock Value
1
BRCC.WS
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
+$1.2M
2
SBFM
Sunshine Biopharma
SBFM
+$1.1M
3
VLNS
The Valens Company, Inc. Common Shares
VLNS
+$688K
4
AIOS
AIOS Tech
AIOS
+$658K
5
STLN
Starling Oncology
STLN
+$504K

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.77%
2 Healthcare 25.83%
3 Technology 25.02%
4 Consumer Staples 0.38%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCDIW
51
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$22K 0.12%
115,814
– –
KWAC.WS
52
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$22K 0.12%
319,125
– –
KBNTW
53
DELISTED
Kubient, Inc. Warrant
KBNTW
$21K 0.11%
80,000
– –
GRNAW
54
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$21K 0.11%
93,837
– –
BBLGW
55
Bone Biologics Corp Warrants
BBLGW
$25M
$20K 0.11%
4,682
– –
DRMAW
56
DELISTED
Dermata Therapeutics Warrant
DRMAW
$19K 0.1%
175,000
– –
REVBW icon
57
Revelation Biosciences Warrant
REVBW
$19K 0.1%
233,382
– –
NLSPW
58
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$18K 0.1%
150,000
– –
GIWWW
59
DELISTED
GigInternational1, Inc. Warrant
GIWWW
$16K 0.09%
297,796
-2,203
-0.7% -$352
LIXTW
60
DELISTED
Lixte Biotechnology Warrants
LIXTW
$12K 0.07%
99,835
-5,428
-5% -$1.1K
CCTSW
61
DELISTED
Cactus Acquisition Corp. 1 Limited Warrant
CCTSW
$11K 0.06%
100,000
– –
BSLKW
62
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$10K 0.05%
126,665
– –
AREBW
63
DELISTED
American Rebel Holdings Warrants
AREBW
$9K 0.05%
602
– –
VLDRW
64
DELISTED
Velodyne Lidar, Inc. Warrants
VLDRW
$9K 0.05%
18,968
– –
QTEKW
65
DELISTED
QualTek Services Inc. Warrant
QTEKW
$7K 0.04%
41,773
– –
TMPMW
66
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$7K 0.04%
99,999
– –
BCDAW
67
DELISTED
BioCardia, Inc. Warrant
BCDAW
$6K 0.03%
18,459
– –
ORIAW
68
DELISTED
Orion Biotech Opportunities Corp. Warrant
ORIAW
$6K 0.03%
39,700
-300
-0.8% -$97
GSQD.WS
69
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$6K 0.03%
40,296
– –
BOAS.WS
70
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$5K 0.03%
31,810
-1,522
-5% -$371
CLAS.WS
71
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$4K 0.02%
50,000
– –
MDAIW icon
72
Spectral AI Warrants
MDAIW
$5.56M
$3K 0.02%
33,336
-1,662
-5% -$296
SBFMW
73
Sunshine Biopharma Inc Warrant
SBFMW
$3K 0.02%
14,986
-220,214
-94% -$389K
MDH.WS
74
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$3K 0.02%
37,500
– –
NRACW
75
DELISTED
Northern Revival Acquisition Corporation Warrant
NRACW
$1K 0.01%
15,961
– –
1 2
3
4

Similar funds

BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $86.6M AUM
LCM
LDR Capital Management New York $86.7M AUM 16.32% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $86.7M AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
TWM
Tripletail Wealth Management Orlando, Florida $86.9M AUM 39.01% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Empery Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Empery Asset Management held 88 positions worth $18.5M, down 13% from $21.3M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Empery Asset Management deployed $6.2M of net new capital in Q2 2022, opening 11 new positions. Its largest new stake was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 75% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Sunshine Biopharma Inc Warrant, an estimated $389K trimmed.

  • Empery Asset Management's largest Q2 2022 buy was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.
  • Empery Asset Management's biggest Q2 2022 reduction was Sunshine Biopharma Inc Warrant, cutting an estimated $389K.
  • Empery Asset Management fully exited BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a in Q2 2022, selling an estimated $1.2M.
  • Empery Asset Management's ten largest holdings make up 80% of its $18.5M portfolio in Q2 2022.
  • Empery Asset Management opened 11 new positions and closed 13 in Q2 2022.
  • Empery Asset Management's portfolio value fell 13% quarter-over-quarter to $18.5M.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.